is januvia a glp-1 vs Tradjenta: Compare Risks and Benefits Diabetes and Januvia (Sitagliptin)
Description
A lot of parts well done, at the right time
CBC, LFTs, renal profile
J Clin Endocrinol Metab 2011;96(10):3067-3077
In a systematic literature review of randomized controlled trials of GLP-1 based therapy in patients with obesity without T2DM, adverse events were reported in 8096 % of patients treated with liraglutide or semaglutide compared with 6396 % of placebo-treated patients
